专题：Lymphoma Diagnosis and Treatment

This cluster of papers focuses on the classification, molecular profiling, genetic pathogenesis, and treatment strategies for various types of lymphoid neoplasms, including Hodgkin's lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and peripheral T-cell lymphoma. It also explores the use of PET imaging, rituximab therapy, and gene expression profiling to predict survival and guide treatment decisions.
最新文献
Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter’s transformation or transformed non-Hodgkin lymphoma: results from a phase I trial

article Full Text OpenAlex

Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study

article Full Text OpenAlex

Comparative risk of incident malignancies in rheumatoid arthritis patients treated with Janus kinase inhibitors or bDMARDs: observational data from the German RABBIT register

article Full Text OpenAlex

Antibody–Drug Conjugates in Gynecologic Cancer: Current Landscape, Clinical Data, and Emerging Targets

review Full Text OpenAlex

R9AP is a common receptor for EBV infection in epithelial cells and B cells

article Full Text OpenAlex

OP0004 ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT LONG TERM OUTCOMES (ALTO) STUDY

article Full Text OpenAlex

EPCORE DLBCL‐3: FIXED‐DURATION EPCORITAMAB MONOTHERAPY IN OLDER (≥ 75 Y), ANTHRACYCLINE‐INELIGIBLE PATIENTS WITH PREVIOUSLY UNTREATED LARGE B‐CELL LYMPHOMA (LBCL)

article Full Text OpenAlex

Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826

article Full Text OpenAlex

Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial

article Full Text OpenAlex

Tumor Microenvironment, Inflammation, and Inflammatory Prognostic Indices in Diffuse Large B-Cell Lymphomas: A Narrative Review

review Full Text OpenAlex

近5年高被引文献
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

review Full Text OpenAlex 2726 FWCI139.786

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

article Full Text OpenAlex 1961 FWCI404.62

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

article Full Text OpenAlex 1138 FWCI92.226

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

article Full Text OpenAlex 1118 FWCI206.378

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

review Full Text OpenAlex 981 FWCI39.433

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

review Full Text OpenAlex 851 FWCI29.028

Diffuse Large B-Cell Lymphoma

review Full Text OpenAlex 797 FWCI30.343

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

article Full Text OpenAlex 611 FWCI126.107

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

article Full Text OpenAlex 600 FWCI77.74

Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial

article Full Text OpenAlex 588 FWCI80.625